1. Home
  2. CRMD vs TRTX Comparison

CRMD vs TRTX Comparison

Compare CRMD & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorMedix Inc.

CRMD

CorMedix Inc.

HOLD

Current Price

$7.87

Market Cap

695.9M

Sector

Health Care

ML Signal

HOLD

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

HOLD

Current Price

$8.65

Market Cap

659.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMD
TRTX
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
695.9M
659.4M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CRMD
TRTX
Price
$7.87
$8.65
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$14.83
$9.83
AVG Volume (30 Days)
1.2M
687.8K
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
11.55%
EPS Growth
780.00
N/A
EPS
0.43
N/A
Revenue
$311,709,000.00
N/A
Revenue This Year
$0.30
$8.78
Revenue Next Year
N/A
$4.14
P/E Ratio
$18.72
$14.82
Revenue Growth
617.03
N/A
52 Week Low
$6.13
$7.57
52 Week High
$14.96
$9.85

Technical Indicators

Market Signals
Indicator
CRMD
TRTX
Relative Strength Index (RSI) 42.72 55.74
Support Level $7.50 $8.59
Resistance Level $9.02 $8.73
Average True Range (ATR) 0.34 0.16
MACD -0.07 0.01
Stochastic Oscillator 13.57 67.00

Price Performance

Historical Comparison
CRMD
TRTX

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

Share on Social Networks: